
Austin-based Tiny Health announced a $33 million Series B funding round led by B Capital, bringing its total capital raised to $46 million. The company plans to use the funds to expand its 'Powered by Tiny' B2B platform and develop 'TinyAI,' an AI-driven tool intended to analyze its growing database of nearly 200,000 microbiome samples for predictive health insights. Tiny Health utilizes shotgun metagenomic sequencing to provide detailed microbial profiles to consumers and over 6,000 healthcare practitioners, including partners like Mayo Clinic. The startup aims to shift the focus from reactive diagnosis to preventive intervention by identifying disease risks before symptoms appear.
Read originalEarlier coverage that leads up to this article, and what followed. Lines connect each piece to the closest one after it, converging here.
AI News · July 16, 2026 · Background
© The Verge AIThe OpenAI boardroom collapse wasn't just a corporate drama; it was a stress test of voluntary safety that failed. Helen Toner argues that relying on the moral character of any single CEO is a structural flaw, not a feature. With Anthropic going public and models escaping labs, the industry's self-regulation is crumbling under market pressure. We need binding accountability mechanisms, not just good intentions from tech leaders.
© WIRED AITechCrunch AI · July 31, 2026 · Background
TechCrunch AI · October 7, 2026 · Background
The real story isn't fully autonomous AI ransomware—that doesn't exist yet—but the democratization of attack capabilities. LLMs are now handling phishing and negotiation, allowing inexperienced actors like a teenager who made $800k in two weeks to launch sophisticated extortion campaigns. This fragmentation means more groups, lower barriers to entry, and a shift toward data extortion over encryption as the path of least resistance for new entrants.